Wonbiogen Balance Sheet Health
Financial Health criteria checks 5/6
Wonbiogen has a total shareholder equity of ₩35.9B and total debt of ₩6.2B, which brings its debt-to-equity ratio to 17.3%. Its total assets and total liabilities are ₩45.6B and ₩9.7B respectively. Wonbiogen's EBIT is ₩6.5B making its interest coverage ratio -27.1. It has cash and short-term investments of ₩14.4B.
Key information
17.3%
Debt to equity ratio
₩6.23b
Debt
| Interest coverage ratio | -27.1x |
| Cash | ₩14.45b |
| Equity | ₩35.91b |
| Total liabilities | ₩9.66b |
| Total assets | ₩45.58b |
Financial Position Analysis
Short Term Liabilities: A307280's short term assets (₩26.0B) exceed its short term liabilities (₩8.9B).
Long Term Liabilities: A307280's short term assets (₩26.0B) exceed its long term liabilities (₩764.9M).
Debt to Equity History and Analysis
Debt Level: A307280 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if A307280's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: A307280's debt is well covered by operating cash flow (126.5%).
Interest Coverage: A307280 earns more interest than it pays, so coverage of interest payments is not a concern.